Developer of a diagnostic device intended to measure blood glucose level in premature infants. The company's technology helps in identification of those premature infants who need an adjustment to their glucose levels, enabling doctors to detect and identify the onset of disease, thus help in improving the health of premature infants.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 22-Oct-2020 | $25K | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Tammy Movsas MD | Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
MassChallenge | Accelerator/Incubator | 000 0000 | 000000 0 |